Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

4basebio AG (4BSB) NPV

Sell:€1.80 Buy:€1.87 Change: €0.1 (5.14%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Takeover

4basebio AG NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 14 Oct 2020)

What is happening?

 

The Board of Sparta AG recently annonunced the terms of a Takeover Offer for the entire issued Share Capital of 4basebio AG. The Takeover is being effected by way of a Tender Offer, under the terms of which holders of 4basebio AG Shares have been offered EUR2.00 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer of EUR2.00 per Share. You can give an instruction to accept the Takeover Offer of EUR2.00 for each 4basebio AG Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer. Proceeds from the Takeover Offer are expected to be received within 3-8 working days following the expiry of the acceptance period, however please note that a firm date for settlement has not been announced.

 

Will I receive any cash proceeds in Euros?

 

No, the proceeds will be converted into Sterling on receipt, subject to the prevailing exchange rate at that time and our standard currency conversion fees.

 

When do I have to decide by?

 

Any instruction to accept the Offer must be received by our deadline of 9am on Monday 19 October 2020.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:€1.80
Buy:€1.87
Change: €0.1 (5.14%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Takeover

4basebio AG NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 14 Oct 2020)

What is happening?

 

The Board of Sparta AG recently annonunced the terms of a Takeover Offer for the entire issued Share Capital of 4basebio AG. The Takeover is being effected by way of a Tender Offer, under the terms of which holders of 4basebio AG Shares have been offered EUR2.00 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer of EUR2.00 per Share. You can give an instruction to accept the Takeover Offer of EUR2.00 for each 4basebio AG Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer. Proceeds from the Takeover Offer are expected to be received within 3-8 working days following the expiry of the acceptance period, however please note that a firm date for settlement has not been announced.

 

Will I receive any cash proceeds in Euros?

 

No, the proceeds will be converted into Sterling on receipt, subject to the prevailing exchange rate at that time and our standard currency conversion fees.

 

When do I have to decide by?

 

Any instruction to accept the Offer must be received by our deadline of 9am on Monday 19 October 2020.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:€1.80
Buy:€1.87
Change: €0.1 (5.14%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Takeover

4basebio AG NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 14 Oct 2020)

What is happening?

 

The Board of Sparta AG recently annonunced the terms of a Takeover Offer for the entire issued Share Capital of 4basebio AG. The Takeover is being effected by way of a Tender Offer, under the terms of which holders of 4basebio AG Shares have been offered EUR2.00 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer of EUR2.00 per Share. You can give an instruction to accept the Takeover Offer of EUR2.00 for each 4basebio AG Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer. Proceeds from the Takeover Offer are expected to be received within 3-8 working days following the expiry of the acceptance period, however please note that a firm date for settlement has not been announced.

 

Will I receive any cash proceeds in Euros?

 

No, the proceeds will be converted into Sterling on receipt, subject to the prevailing exchange rate at that time and our standard currency conversion fees.

 

When do I have to decide by?

 

Any instruction to accept the Offer must be received by our deadline of 9am on Monday 19 October 2020.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Annual & interim reports

Annual & interim reports are not available for this stock.

Financial results for the last 5 years

Financial data for this stock is not available at present.

a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Financials provided by Digital Look Ltd.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.